In this study, the serum IGF-1 concentration was increased in patients with esophageal adenocarcinoma and EC patients with visceral obesity, suggesting that visceral and abdominal obesity might influence the progression of esophageal adenocarcinoma in association with IGF-1 levels [65]. This evidence concerns the gene IGF1 and esophageal adenocarcinoma.